In a study conducted by Sanchez and colleagues with advanced-stage cHL patients from Spain and Houston, a significant correlation was found between high levels of CD68 expression (PG-M1 ve KP1 clones) and shortened duration of disease-specific survival in Spanish patients but no significant association was found with the patient group from Houston and with CD163 (11). This evidence concerns the gene CD68 and classic Hodgkin lymphoma.